Skip to main content
SpringerLink
Log in

AAV-Mediated Gene Transfer to Skeletal Muscle

  • Protocol
Gene Delivery to Mammalian Cells

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 246))

Abstract

Adeno-associated viral (AAV) vectors are derived from a nonpathogenic, replication-deficient virus with a small (∼4.7-kb) single-stranded DNA genome. AAV vectors are devoid of viral-coding sequences and may efficiently transfer genes to nondividing cells such as muscle fibers or hepatocytes following in vivo transduction (1–7). Recombinant AAV can be administered to skeletal muscle of experimental animals and, as recently documented in a Phase I clinical trial, to humans at high vector doses without local or systemic toxicity (8,9). The potential of the vector to activate cytotoxic T lymphocytes is greatly reduced compared with some other viral vectors, thereby reducing the risk of inflammation at the site of gene transfer (7,10,11). Sustained expression of therapeutic transgenes such as coagulation factor IX (F.IX), erythropoietin, leptin, insulin-like growth factor (IGF), sarcoglycans, mini-dystrophin genes, α1-antitrypsin, and others have been demonstrated (2,12–18). Efficient gene transfer to myofibers by intramuscular (im) injection has been shown in several species including mice, hamsters, dogs, and nonhuman primates (6–8,13,19). These studies resulted in various levels of correction of the disease phenoypes in small and large animal models of hemophilia B (F.IX deficiency), muscular dystrophy, obesity, age-related atrophy, and β-thalassemia (8,12,13,15,17,18,20–25).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Clark, K. R., Sferra, T. J., and Johnson, P. R. (1997) Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum. Gene Ther. 8, 659–669.

    Article  PubMed  CAS  Google Scholar 

  2. Kessler, P. D., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P. C, Matelis, L. A., et al. (1996) Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93, 14082–14087.

    Article  PubMed  CAS  Google Scholar 

  3. Nakai, H., Herzog, R., Hagstrom, J. N., Kung, J., Walter, J., Tai, S., et al. (1998) AAV-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 91, 4600–4607.

    PubMed  CAS  Google Scholar 

  4. Snyder, R. O., Miao, C. H., Patijn, G A., Spratt, S. K., Danos, O., Nagy, D., et al. (1997) Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16, 270–276.

    Article  PubMed  CAS  Google Scholar 

  5. Snyder, R. O., Spratt, S. K., Lagarde, C, Bohl, D., Kaspar, B., Sloan, B., et al. (1997) Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther. 8, 1891–1900.

    Article  PubMed  CAS  Google Scholar 

  6. Xiao, X., Li, J., and Samulski, R. J. (1996) Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098–8108.

    PubMed  CAS  Google Scholar 

  7. Fisher, K. J., Jooss, K., Alston, J., Yang, Y., Ehlen-Haecker, S., High, K., et al. (1997) Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3, 306–312.

    Article  PubMed  CAS  Google Scholar 

  8. Herzog, R. W., Yang, E. Y., Couto, L. B., Hagstrom, J. N., Elwell, D., Fields, P. A., et al. (1999) Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat. Med. 5, 56–63.

    Article  PubMed  CAS  Google Scholar 

  9. Kay, M. A., Manno, C. S., Ragni, M. V., Larson, P. J., Couto, L. B., McClelland, A., et al. (2000) Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an A AV vector. Nat. Genet. 24, 257–261.

    Article  PubMed  CAS  Google Scholar 

  10. Fields, P. A., Kowalczyk, D. W., Arruda, V. R., McCleland, M. L., Hagstrom, J. N., K.J., P., Ertl, H. C. J., et al. (2000) Choice of vector determines T cell subsets involved in immune responses against the secreted transgene product factor IX. Mol. Ther. 1, 225–235.

    Article  PubMed  CAS  Google Scholar 

  11. Jooss, K., Yang, Y., Fisher, K. J., and Wilson, J. M. (1998) Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72, 4212–4223.

    PubMed  CAS  Google Scholar 

  12. Cordier, L., Hack, A. A., Scott, M. O., Barton-Davis, E. R., Gao, G., Wilson, J. M., et al. (2000) Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer. Mol. Ther. 1, 119–129.

    Article  PubMed  CAS  Google Scholar 

  13. Greelish, J. P., Su, L. T., Lankford, E. B., Burkman, J. M., Chen, H., Konig, S. K., et al. (1999) Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat. Med. 5, 439–443.

    Article  PubMed  CAS  Google Scholar 

  14. Herzog, R. W., Hagstrom, J. N., Kung, Z.-H., Tai, S. J., Wilson, J. M., Fisher, K. J., and High, K. A. (1997) Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 94, 5804–5809.

    Article  PubMed  CAS  Google Scholar 

  15. Murphy, J. E., Zhou, S., Giese, K., Williams, L. T., Escobedo, J. A., and Dwarki, V. J. (1997) Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin. Proc. Natl. Acad. Sci. USA 94, 13921–13926.

    Article  PubMed  CAS  Google Scholar 

  16. Song, S., Morgan, M., Ellis, T., Poirier, A., Chesnut, K., Wang, J., et al. (1998) Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 95, 14384–14388.

    Article  PubMed  CAS  Google Scholar 

  17. Wang, B., Li, J., and Xiao, X. (2000) Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc. Natl. Acad. Sci. USA 97, 13714–13719.

    Article  PubMed  CAS  Google Scholar 

  18. Barton-Davis, E. R., Shoturma, D. I., Musaro, A., Rosenthal, N., and Sweeney, H. L. (1998) Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl. Acad. Sci. USA 95, 15603–15607.

    Article  PubMed  CAS  Google Scholar 

  19. Ye, X., Rivera, V. M., Zoltick, P., Cerasoli, F., Jr., Schnell, M. A., Gao, G., et al. (1999) Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 283, 88–91.

    Article  PubMed  CAS  Google Scholar 

  20. Bohl, D., Bosch, A., Cardona, A., Salvetti, A., and Heard, J. M. (2000) Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle. Blood 95, 2793–2798.

    PubMed  CAS  Google Scholar 

  21. Chao, H., Samulski, R., Bellinger, D., Monahan, P., Nichols, T., and Walsh, C. (1999) Persistent expression of canine factor IX in hemophilia B canines. Gene Ther. 6, 1695–1704.

    Article  PubMed  CAS  Google Scholar 

  22. Fields, P. A., Arruda, V. R., Armstrong, E., Chu, K., Mingozzi, F., Hagstrom, J. N., et al. (2001) Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in context of a large factor IX gene deletion. Mol. Ther. 4, 201–210.

    Article  PubMed  CAS  Google Scholar 

  23. Herzog, R. W., Mount, J. D., Arruda, V. R., High, K. A., and Lothrop, C. D. J. (2001) Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation. Mol. Ther. 4, 192–200.

    Article  PubMed  CAS  Google Scholar 

  24. Li, J., Dressman, D., Tsao, Y. P., Sakamoto, A., Hoffman, E. P., and Xiao, X. (1999) rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy. Gene Ther. 6, 74–82.

    Article  PubMed  CAS  Google Scholar 

  25. Xiao, X., Li, J., Tsao, Y. P., Dressman, D., Hoffman, E. P., and Watchko, J. F. (2000) Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy. J. Virol. 74, 1436–1442.

    Article  PubMed  CAS  Google Scholar 

  26. Matsushita, T., Elliger, S., Elliger, C., Podsakoff, G., Villarreal, L., Kurtzman, G. J., et al. (1998) Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther. 5, 938–945.

    Article  PubMed  CAS  Google Scholar 

  27. Xiao, X., Li, J., and Samulski, R. J. (1998) Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224–2232.

    PubMed  CAS  Google Scholar 

  28. Chao, H., Liu, Y., Rabinowitz, J., Li, C., Samulski, R. J., and Walsh, C. E. (2000) Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol. Ther. 2, 619–623.

    Article  PubMed  CAS  Google Scholar 

  29. Duan, D., Yan, Z., Yue, Y., Ding, W., and Engelhardt, J. F. (2001) Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation. J. Virol. 75, 7662–7671.

    Article  PubMed  CAS  Google Scholar 

  30. Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., and Wilson, J. M. (1999) Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73, 3994–4003.

    PubMed  CAS  Google Scholar 

  31. Arruda, V. R., Hagstrom, J. N., Deitch, J., Heiman-Patterson, T., Camire, R. M., Chu, K., et al. (2001) Post-translational modifications or recombinant myotube-synthesized human factor IX. Blood 97, 130–138.

    Article  PubMed  CAS  Google Scholar 

  32. Lin, H. F., Maeda, N., Smithies, O., Straight, D. L., and Stafford, D. W. (1997) A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 90, 3962–3966.

    PubMed  CAS  Google Scholar 

  33. Fisher, K. J., Gao, G. P., Weitzman, M. D., DeMatteo, R., Burda, J. F., and Wilson, J. M. (1996) Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520–532.

    PubMed  CAS  Google Scholar 

  34. Bartlett, J. S. and Samulski, R. J. (1996) Methods for the construction and propagation of recombinant adeno-associated virus vectors. Methods Mol. Med. 7, 25–41.

    Google Scholar 

  35. Clark, K. R., Liu, X., McGrath, J. P., and Johnson, P. R. (1999) Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 10, 1031–1039.

    Article  PubMed  CAS  Google Scholar 

  36. Hagstrom, J. N., Couto, L. B., Scallan, C., Burton, M., Arruda, V. R., Fields, P. A., et al. (2000) Enhanced muscle-derived expression of coagulation factor IX from a skeletal actin/CMV hybrid promoter. Blood 95, 2536–2542.

    PubMed  CAS  Google Scholar 

  37. Herzog, R. W., and High, K. A. (1999) Adeno-associated virus-mediated gene transfer of factor IX for treatment of hemophilia B by gene therapy. Thromb. Haemost. 82, 540–546.

    PubMed  CAS  Google Scholar 

  38. Cao, L., Liu, Y., During, M. J., and Xiao, W. (2000) High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids. J. Virol. 74, 11456–11463.

    Article  PubMed  CAS  Google Scholar 

  39. Matsushita, T., Godwin, S., Surosky, R., and Colosi, P. (1999) Proceedings of the 2nd Annual Meeting of the American Society of Gene Therapy. Washington, DC.

    Google Scholar 

  40. Kung, J., Hagstrom, J., Cass, D., Tai, S., Lin, H. F., Stafford, D. W., and High, K. A. (1998) Human F.IX corrects the bleeding diathesis of mice with hemophilia B. Blood 91, 784–790.

    PubMed  CAS  Google Scholar 

  41. Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., et al. (1999) Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973–985.

    Article  PubMed  CAS  Google Scholar 

  42. Auricchio, A., Hildinger, M., O’Connor, E., Gao, G. P., and Wilson, J. M. (2001) Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum. Gene Ther. 12, 71–76.

    Article  PubMed  CAS  Google Scholar 

  43. Gao, G., Qu, G., Burnham, M. S., Huang, J., Chirmule, N., Joshi, B., et al. (2000) Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Hum. Gene Ther. 11, 2079–2091.

    Article  PubMed  CAS  Google Scholar 

  44. Evans, J. P., Brinkhous, K. M., Brayer, G. D., Reisner, H. W., and High, K. A. (1989) Canine hemophilia B resulting from a point mutation with unusual consequences. Proc Natl Acad Sci USA 86, 10095–10099.

    Article  PubMed  CAS  Google Scholar 

  45. Mauser, A. E., Whitlark, J., Whitney, K. M., and Lothrop, C. D., Jr. (1996) A deletion mutation causes hemophilia B in Lhasa Apso dogs. Blood 88, 3451–3455.

    PubMed  CAS  Google Scholar 

  46. Pruchnic, R., Cao, B., Peterson, Z. Q., Xiao, X., Li, J., Samulski, R. J., et al. (2000) The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers. Hum. Gene Ther. 11, 521–536.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Pennsylvania Medical Center and The Children’s Hospital of Philadelphia, Philadelphia, PA

    Roland W. Herzog

Authors
  1. Roland W. Herzog
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Bio-Rad Laboratories, Hercules, CA

    William C. Heiser

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Herzog, R.W. (2004). AAV-Mediated Gene Transfer to Skeletal Muscle. In: Heiser, W.C. (eds) Gene Delivery to Mammalian Cells. Methods in Molecular Biology™, vol 246. Humana Press. https://doi.org/10.1385/1-59259-650-9:179

Download citation

  • DOI: https://doi.org/10.1385/1-59259-650-9:179

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-095-3

  • Online ISBN: 978-1-59259-650-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation